The most comprehensive brief trade study explores the status of the COVID-19 Pharmaceutical Industry and stock market. First, using the developing countries as an illustration, on a global scale, and then on a regional scale in India, we would research the short-term and long-term impact of epidemics on natural resources and the pharmaceutical industry regulations. Identifying these results is important to assist leaders in designing more evidence-based policies to tackle the issues that surround them. Globally we are observing various industries are facing a huge crisis due to the COVID19 pandemic. The coronavirus outbreak is only creating severe hamper to the public health but also to their livelihood. The year 2020 is really a year of crisis for sure, to the financial markets and the world economy. Almost all the sectors and industries were withstanding the economic slowdown. Even large-cap and blue-chip companies were not the exception In spite of such an unprecedented decline in the share prices across the board, there is one segment that has been showing a ray of hope: the pharmaceutical industry. In this article we try to investigate the impact of the covid -19 and consequential on pharma stock prices.